Letter to the EditorTargeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment
Under an Elsevier user license
open archive
Cited by (0)
See also Delierneux C, Donis N, Servais L, Wéra O, Lecut C, Vandereyken M, Musumeci L, Rahmouni S, Schneider J, Eble JA, Lancellotti P, Oury C. Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides. J Thromb Haemost 2017; 15: 983–97 and Delierneux C, Donis N, Servais L, Wera O, Lancellotti P, Oury C. Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply. J Thromb Haemost 2017; https://doi.org/10.1111/jth.13876.
Manuscript handled by: P. H. Reitsma
Final decision: P. H. Reitsma, 16 October 2017
Copyright © 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.